CooperCompanies reported solid financial results for the fiscal fourth quarter and full year ended October 31, 2025.
Revenue for the fourth quarter was $1,065.2 million, showing a 5% increase over the previous year, with organic growth at 3%.
The company's GAAP diluted earnings per share (EPS) for the fourth quarter were $0.43, a decrease of 27%, while the non-GAAP EPS showed positive growth, reaching $1.15, up by 11%.
Financial Performance
Revenue for fiscal year 2025 reached $4.1 billion, marking a 5% increase compared to the previous year, with organic growth at 4%. Non-GAAP diluted EPS for the year was $4.13, showing a 12% increase.
Operational Highlights
CooperVision's revenue in the fourth quarter increased by 5%, with strong performance in different product categories and geographies. CooperSurgical also reported a 4% revenue growth in the same period.
Future Outlook
CooperCompanies aims to drive long-term shareholder value by focusing on accelerating top-line growth, improving profitability, and generating cash flow. The company's disciplined execution and positive outlook for 2026 indicate a strong position for continued growth.
- CooperCompanies' solid financial performance in the fourth quarter and fiscal year 2025 reflects growth in revenue and earnings, driven by strategic initiatives and operational improvements.
- The company's focus on building momentum in key product lines like CooperVision's MyDay and MiSight, combined with successful reorganization activities, positions it for future growth and sustainable profitability.
With a positive outlook for 2026 and a commitment to long-term shareholder value, CooperCompanies demonstrates strength in its operational performance and financial results. The company's focus on growth and profitability sets a promising trajectory for the future.